Fig. 6From: Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR studyAmino acid changes, repeatedly mutated, with evidence of clinical implication, validated by the OncoKB™Back to article page